Natural history of pulmonary function in collagen VI-related myopathies

Brain

Volumn 136, Issue 12, 2013, Pages 3625-3633

  Foley, A Reghan ^a   Quijano Roy, Susana ^b   Collins, James ^c   Straub, Volker ^d   McCallum, Michelle ^d   Deconinck, Nicolas ^e,f   Mercuri, Eugenio ^g   Pane, Marika ^g   D'Amico, Adele ^h   Bertini, Enrico ^h   North, Kathryn ⁱ   Ryan, Monique M ^j   Richard, Pascale ^k,l   Allamand, Valérie ^l,m,n   Hicks, Debbie ^d   Lamandé, Shireen ^j   Hu, Ying ^o   Gualandi, Francesca ^p   Auh, Sungyoung ^o   Muntoni, Francesco ^a   Bönnemann, Carsten G ^o   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b RAYMOND POINCARÉ HOSPITAL   (France)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g CATHOLIC UNIVERSITY   (Italy)

^h BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l SORBONNE UNIVERSITÉ   (France)

^m CNRS   (France)

ⁿ INSERM   (France)

^o NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^p UNIVERSITY OF FERRARA   (Italy)

more..

Author keywords

Collagen VI related myopathies; Forced vital capacity; Natural history; Optimization of care; Outcome measure

Indexed keywords

COLLAGEN TYPE 6;

ADULT; AGE; ARTICLE; AUSTRALIA; BELGIUM; CLINICAL CLASSIFICATION; COHORT ANALYSIS; COLLAGEN VI RELATED MYOPATHY; DISEASE COURSE; FEMALE; FORCED VITAL CAPACITY; FRANCE; HUMAN; ITALY; LIMITED MOBILITY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYOPATHY; NEUROMUSCULAR DISEASE; NONINVASIVE VENTILATION; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED KINGDOM; UNITED STATES; WALKING; ADOLESCENT; ARTIFICIAL VENTILATION; CHILD; CLASSIFICATION; COLLAGEN VI-RELATED MYOPATHIES; DISABILITY; EUROPE; GENETICS; HISTORY; KAPLAN MEIER METHOD; LUNG DISEASE; MIDDLE AGED; MOTOR ACTIVITY; MULTICENTER STUDY; MUSCLE DISEASE; OPTIMIZATION OF CARE; OUTCOME MEASURE; PRESCHOOL CHILD; STATISTICAL MODEL; VITAL CAPACITY; YOUNG ADULT; CLINICAL TRIAL; COMPLICATION; DEFICIENCY; LUNG DISEASES; MUSCULAR DISEASES;

COLLAGEN VI-RELATED MYOPATHIES; FORCED VITAL CAPACITY; NATURAL HISTORY; OPTIMIZATION OF CARE; OUTCOME MEASURE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COLLAGEN TYPE VI; DISABILITY EVALUATION; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; LUNG DISEASES; MALE; MIDDLE AGED; MOTOR ACTIVITY; MUSCULAR DISEASES; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; UNITED STATES; VITAL CAPACITY; YOUNG ADULT;

EID: 84893496921     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt284     Document Type: Article

References (35)

1. Allamand V, Merlini L, Bushby K. 166th ENMC International Workshop on Collagen type VI-related Myopathies, 22-24 May 2009, Naarden, The Netherlands. Neuromuscul Disord 2010; 20: 346-54.
2. Angelin A, Tiepolo T, Sabatelli P, Grumati P, Bergamin N, Golfieri C, et al. Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci USA 2007; 104: 991-6.
3. Bonnemann CG. The collagen VI-related myopathies: muscle meets its matrix. Nat Rev Neurol 2011; 7: 379-90.
4. Bonnemann CG, Rutkowski A, Mercuri E, Muntoni F. 173rd ENMC International Workshop: congenital muscular dystrophy outcome measures 5-7 March 2010, Naarden, The Netherlands. Neuromuscul Disord 2011; 21: 513-22.
5. Bradley WG, Hudgson P, Gardner-Medwin D, Walton JN. The syndrome of myosclerosis. J Neurol Neurosurg Psychiatry 1973; 36: 651-60.
6. Brinas L, Richard P, Quijano-Roy S, Gartioux C, Ledeuil C, Lacene E, et al. Early onset collagen VI myopathies: genetic and clinical correlations. Ann Neurol 2010; 68: 511-20.
7. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010; 9: 77-93.
8. Camacho Vanegas O, Bertini E, Zhang RZ, Petrini S, Minosse C, Sabatelli P, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci USA 2001; 98: 7516-21.
9. Clement EM, Feng L, Mein R, Sewry C, Robb SA, Manzur AY, et al. Relative frequency of congenital muscular dystrophy subtypes: analysis of the UK diagnostic service 2001-2008. Neuromuscul Disord 2012; 22: 522-7.
10. Clinical indications for noninvasive positive pressure ventilation in chronic respiratory failure due to restrictive lung disease, COPD, and nocturnal hypoventilation-a consensus conference report. Chest 1999; 116: 521-34.
11. Finder JD, Birnkrant D, Carl J, Farber HJ, Gozal D, Iannaccone ST, et al. Respiratory care of the patient with Duchenne muscular dystrophy: ATS consensus statement. Am J Respir Crit Care Med 2004; 170: 456-65.
12. Foley AR, Hu Y, Zou Y, Columbus A, Shoffner J, Dunn DM, et al. Autosomal recessive inheritance of classic Bethlem myopathy. Neuromuscul Disord 2009; 19: 813-7.
13. Gualandi F, Urciuolo A, Martoni E, Sabatelli P, Squarzoni S, Bovolenta M, et al. Autosomal recessive Bethlem myopathy. Neurology 2009; 73: 1883-91.
14. Laghi F, Tobin MJ. Disorders of the respiratory muscles. Am J Respir Crit Care Med 2003; 168: 10-48.
15. Littell RC. SAS system for mixed models. Cary, NC: SAS Institute Inc.; 1996.
16. McMenamin JB, Becker LE, Murphy EG. Congenital muscular dystrophy: a clinicopathologic report of 24 cases. J Pediatr 1982; 100: 692-7.
17. Merlini L, Martoni E, Grumati P, Sabatelli P, Squarzoni S, Urciuolo A, et al. Autosomal recessive myosclerosis myopathy is a collagen VI disorder. Neurology 2008; 71: 1245-53.
18. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-38.
19. Misuri G, Lanini B, Gigliotti F, Iandelli I, Pizzi A, Bertolini MG, et al. Mechanism of CO(2) retention in patients with neuromuscular disease. Chest 2000; 117: 447-53.
20. Nadeau A, Kinali M, Main M, Jimenez-Mallebrera C, Aloysius A, Clement E, et al. Natural history of Ullrich congenital muscular dystrophy. Neurology 2009; 73: 25-31.
21. Nicot F, Hart N, Forin V, Boule M, Clement A, Polkey MI, et al. Respiratory muscle testing: a valuable tool for children with neuromuscular disorders. Am J Respir Crit Care Med 2006; 174: 67-74.
22. Okada M, Kawahara G, Noguchi S, Sugie K, Murayama K, Nonaka I, et al. Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan. Neurology 2007; 69: 1035-42.
23. Pan TC, Zhang RZ, Sudano DG, Marie SK, Bonnemann CG, Chu ML. New molecular mechanism for Ullrich congenital muscular dystrophy: a heterozygous in-frame deletion in the COL6A1 gene causes a severe phenotype. Am J Hum Genet 2003; 73: 355-69.
24. Panitch HB. Diurnal hypercapnia in patients with neuromuscular disease. Paediatr Respir Rev 2010; 11: 3-8.
25. Phillips MF, Quinlivan RC, Edwards RH, Calverley PM. Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy. Am J Respir Crit Care Med 2001; 164: 2191-4.
26. Rideau Y, Jankowski LW, Grellet J. Respiratory function in the muscular dystrophies. Muscle Nerve 1981; 4: 155-64.
27. Scacheri PC, Gillanders EM, Subramony SH, Vedanarayanan V, Crowe CA, Thakore N, et al. Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. Neurology 2002; 58: 593-602.
28. Smith PE, Calverley PM, Edwards RH, Evans GA, Campbell EJ. Practical problems in the respiratory care of patients with muscular dystrophy. N Engl J Med 1987; 316: 1197-205.
29. Takaso M, Nakazawa T, Imura T, Okada T, Ueno M, Saito W, et al. Surgical correction of spinal deformity in patients with congenital muscular dystrophy. J Orthop Sci 2010; 15: 493-501.
30. Tiepolo T, Angelin A, Palma E, Sabatelli P, Merlini L, Nicolosi L, et al. The cyclophilin inhibitor Debio 025 normalizes mitochondrial function, muscle apoptosis and ultrastructural defects in Col6a1(-/-) myopathic mice. Br J Pharmacol 2009; 157: 1045-52.
31. Ullrich O. Kongenitale atonisch-sklerotische Muskeldystrophie, ein weiterer Typus der heredodegeneration Erkrankungen des neuromuskulären Systems. Z Ges Neurol Psychiatry 1930; 126: 171-20.
32. Vonesh EF, Chinchilli VM, Pu K. Goodness-of-fit in generalized nonlinear mixed-effects models. Biometrics 1996; 52: 572-87.
33. Wallgren-Pettersson C, Bushby K, Mellies U, Simonds A. 117th ENMC workshop: ventilatory support in congenital neuromuscular disorders-congenital myopathies, congenital muscular dystrophies, congenital myotonic dystrophy and SMA (II) 4-6 April 2003, Naarden, The Netherlands. Neuromuscul Disord 2004; 14: 56-69.
34. Wang CH, Bonnemann CG, Rutkowski A, Sejersen T, Bellini J, Battista V, et al. Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol 2010; 25: 1559-81.
35. Yonekawa T, Komaki H, Okada M, Hayashi YK, Nonaka I, Sugai K, et al. Rapidly progressive scoliosis and respiratory deterioration in Ullrich congenital muscular dystrophy. J Neurol Neurosurg Psychiatry 2013; 84: 982-9.